Safety
hypertriglyceridemia, death, diarrhea
ADVERSE EVENTS, HYPERTRIGLYCERIDEMIA
No AEs leading to death were reported in our study, and one patient experienced treatment discontinuation due to AEs. The most common treatment-related AEs of any grade were diarrhea (94.3%), hypertriglyceridemia (35.8%), and blood creatinine increased (34.0%). Ten patients (18.9%) developed grade 3 diarrhea (Table Treatment-related adverse events occurring in at least 5% patients